Electromed, Inc. (ELMD)
USD 27.0
(-3.98%)
USD 27.0
(-3.98%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 6.58 Million USD | 64.2% |
| 2023 | 4 Million USD | 34.86% |
| 2022 | 2.97 Million USD | -5.35% |
| 2021 | 3.14 Million USD | -38.66% |
| 2020 | 5.11 Million USD | 81.61% |
| 2019 | 2.81 Million USD | -6.32% |
| 2018 | 3 Million USD | -15.71% |
| 2017 | 3.56 Million USD | 14.8% |
| 2016 | 3.1 Million USD | 137.32% |
| 2015 | 1.31 Million USD | 276.91% |
| 2014 | -740.59 Thousand USD | 59.47% |
| 2013 | -1.82 Million USD | -401.38% |
| 2012 | 606.33 Thousand USD | -67.57% |
| 2011 | 1.86 Million USD | 4.12% |
| 2010 | 1.79 Million USD | -26.86% |
| 2009 | 2.45 Million USD | 634.72% |
| 2008 | 334.22 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 142 Thousand USD | -90.5% |
| 2024 Q2 | 2.26 Million USD | 1493.66% |
| 2024 Q3 | 1.84 Million USD | -18.65% |
| 2024 FY | 6.58 Million USD | 64.2% |
| 2024 Q4 | 2.33 Million USD | 26.83% |
| 2023 Q3 | 1.19 Million USD | -6.12% |
| 2023 Q4 | 1.49 Million USD | 24.92% |
| 2023 FY | 4 Million USD | 34.86% |
| 2023 Q1 | 44 Thousand USD | -86.94% |
| 2023 Q2 | 1.27 Million USD | 2795.45% |
| 2022 Q3 | 863 Thousand USD | -19.8% |
| 2022 Q4 | 337 Thousand USD | -60.95% |
| 2022 Q2 | 1.07 Million USD | 100.0% |
| 2022 Q1 | 538 Thousand USD | -17.48% |
| 2022 FY | 2.97 Million USD | -5.35% |
| 2021 Q2 | 1.58 Million USD | 138.73% |
| 2021 Q4 | 652 Thousand USD | 168.33% |
| 2021 FY | 3.14 Million USD | -38.66% |
| 2021 Q1 | 662.98 Thousand USD | -48.61% |
| 2021 Q3 | 242.98 Thousand USD | -84.65% |
| 2020 Q4 | 1.29 Million USD | 41.28% |
| 2020 Q3 | 913.1 Thousand USD | -41.73% |
| 2020 Q2 | 1.56 Million USD | 16.19% |
| 2020 Q1 | 1.34 Million USD | -9.22% |
| 2020 FY | 5.11 Million USD | 81.61% |
| 2019 FY | 2.81 Million USD | -6.32% |
| 2019 Q4 | 1.48 Million USD | 221.71% |
| 2019 Q1 | 198.94 Thousand USD | -87.5% |
| 2019 Q2 | 672.21 Thousand USD | 237.9% |
| 2019 Q3 | 461.77 Thousand USD | -31.31% |
| 2018 Q4 | 1.59 Million USD | 227.95% |
| 2018 FY | 3 Million USD | -15.71% |
| 2018 Q3 | 485.1 Thousand USD | -37.01% |
| 2018 Q2 | 770.17 Thousand USD | 374.48% |
| 2018 Q1 | 162.31 Thousand USD | -89.28% |
| 2017 FY | 3.56 Million USD | 14.8% |
| 2017 Q2 | 729.45 Thousand USD | 152.51% |
| 2017 Q3 | 1.03 Million USD | 42.13% |
| 2017 Q4 | 1.51 Million USD | 46.05% |
| 2017 Q1 | 288.87 Thousand USD | -46.39% |
| 2016 Q4 | 538.87 Thousand USD | -26.75% |
| 2016 Q3 | 735.68 Thousand USD | -41.12% |
| 2016 Q1 | 585.16 Thousand USD | 43.69% |
| 2016 Q2 | 1.24 Million USD | 113.54% |
| 2016 FY | 3.1 Million USD | 137.32% |
| 2015 Q2 | 447.38 Thousand USD | 12.41% |
| 2015 Q1 | 397.98 Thousand USD | 9.8% |
| 2015 Q4 | 407.24 Thousand USD | 607.22% |
| 2015 Q3 | 57.58 Thousand USD | -87.13% |
| 2015 FY | 1.31 Million USD | 276.91% |
| 2014 FY | -740.59 Thousand USD | 59.47% |
| 2014 Q1 | -577.2 Thousand USD | -30.65% |
| 2014 Q4 | 362.46 Thousand USD | 266.99% |
| 2014 Q2 | -308.79 Thousand USD | 46.5% |
| 2014 Q3 | -217.06 Thousand USD | 29.71% |
| 2013 Q2 | -595.41 Thousand USD | -517.84% |
| 2013 Q1 | -96.37 Thousand USD | 43.99% |
| 2013 Q3 | -693.8 Thousand USD | -16.53% |
| 2013 Q4 | -441.8 Thousand USD | 36.32% |
| 2013 FY | -1.82 Million USD | -401.38% |
| 2012 Q3 | 225.77 Thousand USD | 125.46% |
| 2012 Q2 | 100.14 Thousand USD | -77.87% |
| 2012 FY | 606.33 Thousand USD | -67.57% |
| 2012 Q4 | -172.04 Thousand USD | -176.2% |
| 2012 Q1 | 452.46 Thousand USD | 11.0% |
| 2011 Q4 | 407.6 Thousand USD | -39.3% |
| 2011 Q2 | 543.03 Thousand USD | 119.18% |
| 2011 Q1 | 247.75 Thousand USD | -11.76% |
| 2011 Q3 | 671.5 Thousand USD | 23.66% |
| 2011 FY | 1.86 Million USD | 4.12% |
| 2010 FY | 1.79 Million USD | -26.86% |
| 2010 Q2 | 170.62 Thousand USD | -72.51% |
| 2010 Q3 | 764.26 Thousand USD | 347.91% |
| 2010 Q4 | 280.78 Thousand USD | -63.26% |
| 2010 Q1 | 620.69 Thousand USD | 37.57% |
| 2009 Q4 | 451.17 Thousand USD | 0.0% |
| 2009 FY | 2.45 Million USD | 634.72% |
| 2008 FY | 334.22 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Myomo, Inc. | -8.23 Million USD | 179.949% |
| Senseonics Holdings, Inc. | -75.6 Million USD | 108.705% |
| Catheter Precision, Inc. | -78.11 Million USD | 108.424% |
| Xtant Medical Holdings, Inc. | -10.15 Million USD | 164.786% |